SequelSEC

GoodRx Holdings, Inc. GDRX

Services-Computer Processing & Data Preparation · CIK 0001809519 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$200.41M
Fiscal year ended 2026-06-30
Operating income
$23.63M
Fiscal year ended 2026-06-30
Free cash flow
$80.47M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$423.20MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float / net income13.9×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.5×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Computer Processing & Data Preparation filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Effective tax rate46.2%89th
Operating margin11.0%81th
Revenue YoY growth0.6%25th
CapEx / revenue0.4%26th
FCF margin20.6%74th
Current ratio2.61x70th
Net margin3.8%62th
Long-term debt / equity0.78x60th
R&D / revenue15.2%41th
SBC / revenue9.6%54th

GoodRx Holdings, Inc. (GDRX) reported revenue of $200.41M and net income of $8.54M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from GoodRx Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Processing & Data Preparation.

Income

GoodRx Holdings, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$200.41M$194.01M$194.78M$196.03M$203.07M$202.97M$198.58M$195.25M$200.61M$197.88M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income$23.63M$14.01M$22.68M$14.62M$26.81M$23.38M$18.18M$20.41M$19.88M$7.38M
Net income$8.54M$1.17M$5.42M$1.12M$12.84M$11.05M$6.74M$3.96M$6.69M-$1.01M
Research & development$26.71M$30.18M$28.94M$31.01M$29.93M$31.14M$31.74M$30.14M$30.85M$31.02M
Weighted-average diluted sharesshares 348.06Mshares 341.42MUnavailableshares 347.81Mshares 357.16Mshares 379.66MUnavailableshares 388.50Mshares 384.73Mshares 390.05M
Pretax income$15.47M$5.64M$14.19M$6.10M$19.58M$16.67M$11.41M$8.11M$11.65M$293.00K
Income tax expense$6.93M$4.47M$8.77M$4.98M$6.73M$5.62M$4.67M$4.15M$4.95M$1.30M
Diluted EPS$0.02$0.00Unavailable$0.00$0.04$0.03Unavailable$0.01$0.02$0.00
Selling, general & administrative$106.80M$107.87M$102.55M$115.55M$113.25M$114.17M$117.38M$115.49M$121.04M$131.07M
General & administrative$24.81M$26.82M$23.94M$32.01M$28.38M$29.63M$23.55M$25.62M$27.59M$41.11M
Selling & marketing$81.99M$81.05M$78.62M$83.53M$84.87M$84.54M$93.83M$89.87M$93.45M$89.96M

Balance

GoodRx Holdings, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$296.11M$235.71M$261.82M$273.53M$281.32M$300.98M$448.35M$423.78M$524.90M$533.30M
Total assets$2.34B$2.02B$1.40B$1.33B$1.32B$1.30B$1.39B$1.35B$1.48B$1.45B
Current assets$1.60B$1.27B$643.10M$565.52M$550.61M$540.21M$659.26M$626.80M$750.56M$732.80M
Total liabilities$1.70B$1.40B$787.80M$724.80M$675.68M$640.92M$663.41M$658.41M$805.99M$822.89M
Current liabilities$1.16B$859.20M$246.00M$181.86M$130.91M$103.38M$123.90M$114.36M$102.47M$116.52M
Total equity incl. NCI$647.60M$621.99M$616.26M$600.71M$643.03M$654.35M$724.66M$696.43M$669.40M$631.07M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$182.14M$232.72M$235.75M$203.74M$189.03M$160.12M$145.93M$130.80M$161.77M$144.77M
Goodwill$430.33M$430.33M$430.33M$421.72M$421.72M$421.72M$410.77M$410.77M$410.77M$410.77M
Long-term debt$481.59M$482.42M$483.26M$484.11M$484.97M$485.84M$486.71M$487.59M$645.65M$646.68M
Accounts payable$8.91M$14.52M$19.40M$28.72M$25.41M$15.26M$14.14M$12.39M$16.88M$33.52M

Cash flow

GoodRx Holdings, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow$80.83M$11.84M$32.89M$76.02M$49.58M$9.41M$44.74M$86.86M$9.70M$42.59M
Capital expenditures$362.00K$1.14M$1.24M$1.75M$390.00K$142.00K$162.00K$403.00K$268.00K$407.00K
Investing cash flow-$14.41M-$21.64M-$31.77M-$18.00M-$18.32M-$51.88M-$16.64M-$15.86M-$17.23M-$20.62M
Financing cash flow-$6.02M-$16.30M-$12.83M-$65.81M-$50.93M-$104.90M-$3.53M-$172.13M-$864.00K-$160.97M
Net change in cash$60.40M-$26.11M-$11.71M-$7.79M-$19.66M-$147.36M$24.57M-$101.13M-$8.39M-$139.00M
Stock-based compensation$16.59M$16.51M$17.92M$18.12M$21.42M$19.17M$20.96M$26.38M$26.59M$25.10M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$1.95M$12.57M$9.43M$61.05M$45.99M$99.90M$188.00K$5.43M$0$153.23M
Depreciation & amortization$22.27M$21.79M$23.15M$21.43M$19.73M$20.91M$19.10M$17.54M$16.96M$15.94M

Derived

GoodRx Holdings, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow$80.47M$10.70M$31.65M$74.28M$49.19M$9.27M$44.58M$86.46M$9.43M$42.18M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin11.8%7.2%11.6%7.5%13.2%11.5%9.2%10.5%9.9%3.7%
FCF margin40.2%5.5%16.2%37.9%24.2%4.6%22.4%44.3%4.7%21.3%
SBC / revenue8.3%8.5%9.2%9.2%10.5%9.4%10.6%13.5%13.3%12.7%
Current ratio1.38x1.47x2.61x3.11x4.21x5.23x5.32x5.48x7.32x6.29x
Revenue YoY growth-1.3%-4.4%-1.9%0.4%1.2%2.6%1.0%8.5%5.8%7.6%
Net margin4.3%Unavailable2.8%0.6%6.3%Unavailable3.4%2.0%UnavailableUnavailable
R&D / revenue13.3%15.6%14.9%15.8%14.7%15.3%16.0%15.4%15.4%15.7%
CapEx / revenue0.2%0.6%0.6%0.9%0.2%0.1%0.1%0.2%0.1%0.2%
Long-term debt / equity0.74xUnavailable0.78x0.81xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate44.8%79.3%61.8%81.7%34.4%33.7%40.9%51.1%42.5%444.4%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GDRX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.